Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
KUZE, 11% Decrease in Ordinary Profit for The Current Fiscal Year
2708 KUZE CO., LTD. 【J-GAAP】
Earnings ReportKUZE CO., LTD. <2708> [TSE Std] announced its financial results after the market closed on May 15th (15:40). The consolidated ordinary profit for the fiscal year ending March 2025 increased 13.0% from the previous period to 2.19 billion yen. However, for the fiscal year ending March 2026, the consolidated ordinary profit is expected to decrease by 11.0% from the previous period to 1.95 billion yen.
In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit surged 3.8 times that of the same period last year, reaching 0.28 billion yen. The operating profit margin improved from 0.4% in the same period last year to 1.9%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2023 | 56,460 | 842 | 900 | 832 | 181.0 | 12 | May 15, 2023 | J-GAAP |
| Mar, 2024 | 64,474 | 1,861 | 1,939 | 2,008 | 434.1 | 42 | May 15, 2024 | J-GAAP |
| Mar, 2025 | 68,568 | 1,847 | 2,191 | 1,754 | 379.4 | 42 | May 15, 2025 | J-GAAP |
| YoY | +6.3% | -0.8% | +13.0% | -12.6% | -12.6% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2025 Guidance | 72,150 | 1,700 | 2,050 | 1,650 | 356.7 | 42 | Feb 28, 2025 | J-GAAP |
| Mar, 2025 Results | 68,568 | 1,847 | 2,191 | 1,754 | 379.4 | 42 | May 15, 2025 | J-GAAP |
| Revision Rate | -5.0% | +8.6% | +6.9% | +6.3% | +6.4% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2024 | 33,434 | 736 | 871 | 896 | 193.7 | 0 | Nov 14, 2024 | J-GAAP |
| Apr - Sep, 2025 Guidance | 34,000 | 760 | 790 | 510 | 110.2 | 0 | May 15, 2025 | J-GAAP |
| YoY | +1.7% | +3.3% | -9.3% | -43.1% | -43.1% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 64,474 | 1,861 | 1,939 | 2,008 | 434.1 | 42 | May 15, 2024 | J-GAAP |
| Mar, 2025 | 68,568 | 1,847 | 2,191 | 1,754 | 379.4 | 42 | May 15, 2025 | J-GAAP |
| Mar, 2026 Guidance | 71,000 | 1,920 | 1,950 | 1,250 | 270.2 | 42 | May 15, 2025 | J-GAAP |
| YoY | +3.5% | +4.0% | -11.0% | -28.7% | -28.8% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 15,410 | 54 | 76 | 64 | 13.8 | 0.4 | May 15, 2024 | J-GAAP |
| Apr - Jun, 2024 | 17,018 | 424 | 448 | 624 | 135.0 | 2.5 | Aug 14, 2024 | J-GAAP |
| Jul - Sep, 2024 | 16,416 | 312 | 423 | 272 | 58.8 | 1.9 | Nov 14, 2024 | J-GAAP |
| Oct - Dec, 2024 | 18,541 | 801 | 1,031 | 665 | 143.8 | 4.3 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 16,593 | 310 | 289 | 193 | 41.7 | 1.9 | May 15, 2025 | J-GAAP |
| YoY | +7.7% | +474.1% | +280.3% | +201.6% | +201.6% |
Related Articles
SOURCENEXT, Last Fiscal Year's Net Income Loss Widens, Current period performance is undisclosed.
Yashima Denki, 6% Increase in Ordinary Profit, Update Record High for Fourth Consecutive Term, Dividend Raised by 4 yen
RESORTTRUST, 2% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, Increased Previous Year's Dividend by 2 yen, This Fiscal Year to Increase Dividend
PhoenixBio, Returning to Profitability This Year
KURAMOTO, Jan-Mar (1Q) Net Income Turns to Loss
ICDA Holdings, 4% Increase in Ordinary Profit, Update Record High for Third Consecutive Term
KUBOTEK, The Current Fiscal Year's Net Income to Widen
LUCKLAND, Jan-Mar (1Q) Ordinary Profit Increases by 2.2 times
Delta-Fly Pharma, The Current Fiscal Year's Net Income to Narrow
AIMECHATEC, Jul-Mar (Cumulative 3Q) Ordinary Profit Turns to Profit, Jan-Mar Ordinary Profit Loss Narrows